Ultragenyx Pharmaceutical, Inc. RARE 深 沪
等待开盘 08-20 09:30:00 美东时间
26.24
+0.750
+2.94%
华盛通- 最 高26.68
- 今 开26.28
- 成交量 284.49万股
- 最 低 26.00
- 昨 收 25.49
- 总市值 25.87亿
- 52周最高 39.8899
- 市盈率 静 --
- 换手率 2.89%
- 52周最低 18.29
- 委 比 31.12%
- 总股本 9858.89万
- 历史最高 179.647
- 量 比 2.08
- 振 幅 2.67%
- 历史最低 18.29
- 每 手 1
- 风险率 4.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biggest stock movers Thursday: Crypto stocks, WOLF, and more
Stock futures were lower early Thursday as persistent geopolitical tensions in the Middle East drove Brent crude over $92 a barrel, reinforcing broader inflation concerns. Risk appetite remains constr...
今天 17:01
美股夜盘 | 微牛暴升15.05%，Ultragenyx Pharmaceutical, Inc.暴升14.29%
微牛暴升15.05%；Ultragenyx Pharmaceutical, Inc.暴升14.29%；BitMine Immersion Technologies大升7.41%
今天 15:01
美股夜盘 | 微牛暴升14.58%，Ultragenyx Pharmaceutical, Inc.劲升10.90%
微牛暴升14.58%；Ultragenyx Pharmaceutical, Inc.劲升10.90%；Nordson大升6.80%
今天 13:01
美股夜盘 | 微牛暴升14.00%，BitMine Immersion Technologies大升7.56%
微牛暴升14.00%；BitMine Immersion Technologies大升7.56%；Ultragenyx Pharmaceutical, Inc.大升7.47%
今天 10:01
美股夜盘 | 微牛暴升12.96%，BitMine Immersion Technologies大升7.26%
微牛暴升12.96%；BitMine Immersion Technologies大升7.26%；Nordson大升6.80%
今天 09:01
Ultragenyx Earnings Call Signals Record Sales, 2027 Pivot
Ultragenyx Pharmaceutical, Inc. (($RARE)) has held its Q2 earnings call. Read o...
今天 08:28
美股夜盘 | 微牛暴升13.77%，BitMine Immersion Technologies大升6.87%
Wolfspeed Inc急跌9.08%；Moderna大跌5.67%；亚朵集团下跌2.68%
今天 08:06
Ultragenyx Pharmaceutical Obtains FDA Accelerated Approval For GENGLYCOS In Adult And Pediatric Patients Eight Years And Older With Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for GENGLYCOS™ (pariglasgene brecaparvovec-opnr), also known as DTX401, in adult and pediatric patients eight years and older with glycogen storage disease type ...
今天 05:24
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
